CBD

Why moving to the right could be wrong for Dutton and the Coalition

Retrieved on: 
Wednesday, April 10, 2024
Well, Health, Red meat, Social, Coalition, House of Representatives, Liberal, Representative, Female, Policy, News, Politics, CBD, Life, House, Masculinity, Woman, Housing, Human voice, Nuclear energy, Heart, Liberal Party, Government, Senate

When Peter Dutton took the Coalition reins in 2022 after a humiliating loss of office, his first priority was unity.

Key Points: 
  • When Peter Dutton took the Coalition reins in 2022 after a humiliating loss of office, his first priority was unity.
  • A punchy and well-schooled parliamentarian, Dutton knew that if ever he was to contest the prime ministership, his primary challenge was to make it to the next election.
  • The alienation this policy creates among mainstream urban voters could more than offset its popularity in the joint party room (particularly within the anti-renewables Nationals).
  • They joined Warringah (NSW) on Sydney’s North Shore, lost spectacularly in 2019 to the original “teal”, Zali Steggall.
  • Read more:
    Labor's unexpected Aston win is body blow for Dutton

    The bad news has kept on coming.

  • That needless act, and the brash language justifying it, brought no interjection from Dutton.
  • It was an example of just the kind of braggadocio that could see even more Liberal women heading for the exits.


Mark Kenny does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

BT CBD CORP Unveils a Revolutionary THCA Flower Collection, Setting New Standards of Quality and Purity

Retrieved on: 
Friday, April 5, 2024
CBD, Attention, THCA, Snow, Flower

Raleigh, North Carolina--(Newsfile Corp. - April 5, 2024) - With the latest developments, BT CBD CORP unveils a cutting-edge THCA flower collection. The company aims to provide pure and potent Hemp Flowers sourced from certified organic farms. With its high-quality THCA flower and a wide range of premium CBD products, the company aims to ensure that every product meets high standards of quality and potency.

Key Points: 
  • Summary: BT CBD CORP, operating under the brand name Black Tie CBD, has been setting the standard for excellence in the smokable hemp industry.
  • Raleigh, North Carolina--(Newsfile Corp. - April 5, 2024) - With the latest developments, BT CBD CORP unveils a cutting-edge THCA flower collection.
  • With its high-quality THCA flower and a wide range of premium CBD products, the company aims to ensure that every product meets high standards of quality and potency.
  • With the FRUITY LOOPS (INDOOR), THC-A Flower underscores BT CBD CORP's reputation for delivering top-tier products that exceed industry standards.

Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup

Retrieved on: 
Thursday, April 4, 2024
Melon, Cream, CBG, Culture, Burn, Limonene, Hibiscus, Gasoline, TLRY, Snow, Partnership, Lotus, CBD, GOOD, TSX, Love, Cranberry, Cheese, Fruit, Ammonia, Candy, THC, Citrus, Drug

TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis lifestyle and consumer packaged goods company, through its wholly-owned licensed subsidiaries, Aphria Inc., Hexo Operations Inc., and Truss Beverages Company Limited, announces its latest product lineup and 420 celebratory activations across Canada.

Key Points: 
  • TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis lifestyle and consumer packaged goods company, through its wholly-owned licensed subsidiaries, Aphria Inc., Hexo Operations Inc., and Truss Beverages Company Limited, announces its latest product lineup and 420 celebratory activations across Canada.
  • Cannabis enthusiasts and cannabis-curious consumers alike are invited to learn about Tilray Brands’ products at local cannabis retailers.
  • In celebration of 420 and the ever-changing landscape of cannabis innovation and culture, Tilray Brands invites consumers to explore a new range of diverse cannabis products from its leading brands.
  • Broken Coast EmergenZ and Cherry Cheesecake: Broken Coast presents two exceptional strains for 420 with unique aromas and taste profiles.

IMPROVING HEMP YIELDS TO INCREASE PROFTABILITY FOR FARMERS

Retrieved on: 
Thursday, April 4, 2024
Dicarboxylic acid, Farmer, Grain, Growth, Rotation, FHF, The Honourable, Economic development, CBD, Health Canada, FBN, Parity, Breeding, HGI, Farmers Business Network, Verve, Agriculture

During the five-year project, partners will work to position hemp as a protein-rich crop with increased yields and expanded ingredient and food usages.

Key Points: 
  • During the five-year project, partners will work to position hemp as a protein-rich crop with increased yields and expanded ingredient and food usages.
  • “Improving the yield of hemp increases the profitability of the crop, bringing benefit to farmers, while also bringing more healthy and sustainable high-protein options for ingredient manufacturers and food processors.”
    Fresh Hemp Foods, Farmer’s Business Network Canada and Verve are industry leaders in their respective fields.
  • FBN manages hybrid canola and hemp breeding programs and together with Verve has the largest hemp seed genetics portfolio in North America.
  • Fresh Hemp Foods, established in 1998, is a global leader in contract hemp production, food ingredient processing and hemp-based consumer packaged goods.

RC Show 2024 Releases Sneak Peek at its Dynamic Speaker Lineup

Retrieved on: 
Wednesday, April 3, 2024
The French Laundry, History, Workshop, Wine, ICAN, Restaurant, THC, Accident, DEI, Interac, Inclusion, Certification, LEVEL, Diversity, Coffee, Cannabis, Interim, Breakfast, Organization, MasterClass, Woman, Philosophy, Food, BDC, Introduction, RC, Happy Accidents, Guinness, Family, Food safety, Wagman, Netflix, Ipsos, Blueprint, CBD, Life, Collection, Management

Learn about the latest innovations, valuable insights, current issues, and discover solutions that will help support the industry going forward.

Key Points: 
  • Learn about the latest innovations, valuable insights, current issues, and discover solutions that will help support the industry going forward.
  • RC Show gives attendees access to world-class educational and interactive speaker sessions, workshops and panels over three days, across six stages.
  • Here’s a taste of this year’s programming highlights and who RC Show is bringing to the table:
    Kick off the RC Show Speaker Series with a bang.
  • Catch her bartending skills live and up-close on the RC Pop-Up Stage April 9, 11 a.m.-1 p.m.

Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use

Retrieved on: 
Wednesday, April 3, 2024
Epilepsy, CCPS, Health, TLRY, HIV, Arthritis, Post-traumatic stress disorder, Patient, Tilray, Anxiety, Tobacco, Chronic pain, CBD, Essential tremor, Cannabis, TSX, Signs and symptoms, Pain, THC, Vomiting, Pharmaceutical industry

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, today announced a new Tilray led scientific publication, Age-related Patterns of medical Cannabis Use: A Survey of Authorized Patients in Canada. The new study was derived from the Canadian Cannabis Patient Survey (CCPS) 2021, comprised of 2,697 patients and focused primarily on older patients with a mean age of 54.3. This study presents to the medical and scientific community the consumption trends observed in patients and the self-reported impacts from medical cannabis in alleviating the patients’ primary symptoms.

Key Points: 
  • Tilray Led Study Shows Chronic Pain, Arthritis, Anxiety, and Insomnia as Primary Illnesses and Symptoms for Medical Cannabis Use
    NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, today announced a new Tilray led scientific publication, Age-related Patterns of medical Cannabis Use: A Survey of Authorized Patients in Canada .
  • This study presents to the medical and scientific community the consumption trends observed in patients and the self-reported impacts from medical cannabis in alleviating the patients’ primary symptoms.
  • The Age-related Patterns of Medical Cannabis Use study finds that older patients comprise a growing subset of medical cannabis patients.
  • José Tempero, Tilray’s Medical Director, said, "Our role in this initiative exemplifies our commitment to medical research, leading us one step closer to unlocking the full therapeutic potential of medical cannabis."

Pressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”

Retrieved on: 
Tuesday, April 2, 2024
Absorption, Açaí palm, Hemp, D3, UST, Business development, CBD, Human, Collection, Marketing, Plant, Commonwealth, Wellness, OTCQB, Animal, Agriculture, Pharmaceutical industry

CANTON, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services for the health & wellness, food & beverage, nutraceutical, cosmeceutical, and other industries, today announced that its wholly-owned Uncle Bud’s Health & Wellness consumer packaged goods subsidiary (“Uncle Bud’s”) has experienced significant sales activity in its revolutionary nanoemulsified CBD product offered in the initial launch of its highly touted “Premium Collection” of UltraShear™ processed nanoemulsion products. Click here for more info on Uncle Bud's Premium Collection.

Key Points: 
  • Click here for more info on Uncle Bud's Premium Collection.
  • The Premium Collection was an immediate success, highlighted by the unprecedented response to its initial product in the Collection - the CBD Body Revive Spray with 1200mg of Nano-CBD.
  • “Uncle Bud’s newly launched Nano-CBD Body Revive Spray, an innovative, all plant-based, organic, highly bioavailable flagship product processed using PBIO’s UltraShear platform, captured an impressive 30% conversion of Uncle Bud’s total CBD Revive Spray product revenue in March alone,” commented John Hollister, PBIO’s Director of Sales and Marketing.
  • This achievement enables PBIO to develop, manufacture, market, and sell UST-processed products into the rapidly expanding CBD marketplace.

Avicanna Reports Full Year 2023 Audited Financial Results 

Retrieved on: 
Tuesday, April 2, 2024
Cream, Cannabidiol, Cannabinoid, Dravet syndrome, Brazilian Health Regulatory Agency, Interest, Medical cannabis, Seizure, Business, Lennox–Gastaut syndrome, Patient, Pharmacy, Active ingredient, Research, Acquisition, RDC, Ultra, Stock, CBD, Insurance, Health Canada, Bank statement, GMP, Dermatology, TSX, Therapy, Pharmaceutical industry

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.

Key Points: 
  • TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.
  • Cash used in operations of $1.38 million; an 81% reduction compared to $7.4 million in 2022.
  • “2023 was a tremendous year for Avicanna where we solidified of our leadership position in the Canadian medical cannabis sector through our proprietary products and the launch of MyMedi.ca.
  • We have successfully demonstrated the scalability of our revenues and made significant improvements in our fundamentals while advancing all our business pillars.

New to The Street and Hempacco Co., Inc. Sign Three Month Media Contract

Retrieved on: 
Thursday, March 28, 2024
Fox Business, Growth, Entrepreneurship, Digital, Social media, Smoker, Tobacco, Interview, Smoke, CBD, Cannabis, IP, Hemp, Dennis Eichhorn

NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ: HPCO) ($HPCO) ("Hempacco") signed a three-month media contract.

Key Points: 
  • NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ: HPCO) ($HPCO) ("Hempacco") signed a three-month media contract.
  • The New to The Street's social media team will share media content, creating a platform to increase awareness about HPCO.
  • New to The Street is a perfect media platform to inform many about HPCO's hemp CBD product offerings and collaborations.
  • I look forward to continuing with the professional media experts at New to The Street."

Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation

Retrieved on: 
Wednesday, March 27, 2024
Cannabinoid, Absorption, Dravet syndrome, Seizure, Lennox–Gastaut syndrome, Patient, Research, CBD, Health Canada, TSX, THC, Plasma protein binding, RHO

TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the launch of RHO Phyto Micro Drop 100, a 10% CBD (THC free), proprietary oral formulation in Canada. RHO Phyto Micro Drop 100, is designed to deliver enhanced absorption of cannabinoids through an inverted emulsion technology. RHO Phyto Micro Drop 100 will be available to Canadian patients with medical authorization exclusively at the MyMedi.ca medical cannabis care platform.

Key Points: 
  • TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the launch of RHO Phyto Micro Drop 100, a 10% CBD (THC free), proprietary oral formulation in Canada.
  • RHO Phyto Micro Drop 100, is designed to deliver enhanced absorption of cannabinoids through an inverted emulsion technology.
  • RHO Phyto Micro Drop 100 will be available to Canadian patients with medical authorization exclusively at the MyMedi.ca medical cannabis care platform.
  • RHO Phyto Micro Drop 100 contains the same proprietary oral formulation as the product Trunerox™.